Cause of a tender, Kosovo cancer patients who remain without therapy for 2 years

Since February 2017, cancer patients do not have one of the important cytostatics to treat the disease. For about two years, MS has been failing to contract the Chisplatin bar.

This is because the Health Ministry has decided to cancel the tender initiated more than a year ago. The reasons, according to the SHU, have been the high price for the chip compared to the market price, are written today. Koha Ditore.

However, the Procureing Organisation has ordered the MS to sign the contract. The OSP, which is known as the “tender laws” two weeks ago, has considered that Minister Ismaili's refusal to sign the tender is not legal.

So why the price offered by the company for this product is more expensive than the market price, the OSP has been labelled irregularly withdrawing from the signing of this tender.

In an ordinance issued for MS two weeks ago, this institution highlighted the violation of Article 59 of the Public Procurement Law when it decided not to sign this contract.